Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lobular in Situ Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00952731
What this trial is testing

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Northwestern University 27
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046
What this trial is testing

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more
Alliance for Clinical Trials in Oncology 86
Large-scale testing (Phase 3)Study completedNCT00002920
What this trial is testing

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Who this might be right for
Breast CancerEndometrial Cancer
SWOG Cancer Research Network 313
Not applicableStudy completedNCT01407770
What this trial is testing

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Who this might be right for
Breast CancerCognitive Ability, GeneralFatigue+4 more
Wake Forest University Health Sciences 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Not applicableUnknownNCT00967239
What this trial is testing

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,881
Not applicableStudy completedNCT02224807
What this trial is testing

Effects of Diet and Exercise on Ductal Carcinoma in Situ

Who this might be right for
Ductal Carcinoma In SituBreast Cancer
University of Alabama at Birmingham 32
Not applicableStudy completedNCT03430765
What this trial is testing

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy

Who this might be right for
Persistent Postsurgical PainBreast Cancer FemaleDuctal Carcinoma in Situ
Katherine Hadlandsmyth 62
Not applicableEnded earlyNCT02023008
What this trial is testing

Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy

Who this might be right for
Anxiety DisorderDepressionDuctal Breast Carcinoma in Situ+7 more
Wake Forest University Health Sciences 6
Not applicableStudy completedNCT02121873
What this trial is testing

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

Who this might be right for
Breast CancerPreneoplastic ConditionsDuctal Carcinoma in Situ
Atossa Therapeutics, Inc. 6
Not applicableStudy completedNCT05086705
What this trial is testing

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ+1 more
Ohio State University Comprehensive Cancer Center 50
Not applicableStudy completedNCT00666731
What this trial is testing

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
University of Nebraska 4,945
Not applicableWithdrawnNCT00041353
What this trial is testing

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Who this might be right for
Breast Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04666961
What this trial is testing

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Who this might be right for
Ductal Carcinoma in SituExtensive DiseaseMastectomy
Institut Cancerologie de l'Ouest 262
Not applicableLooking for participantsNCT07478016
What this trial is testing

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
Thomas Jefferson University 200
Not applicableStudy completedNCT02216136
What this trial is testing

Tumor: Breast Ratio Study

Who this might be right for
Breast CancerLCISDCIS
Washington University School of Medicine 162
Not applicableLooking for participantsNCT05178498
What this trial is testing

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more
Ohio State University Comprehensive Cancer Center 960
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Not applicableLooking for participantsNCT06350500
What this trial is testing

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma in Situ
Roswell Park Cancer Institute 126
Not applicableStudy completedNCT00804128
What this trial is testing

Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Breast Cancer
University of California, San Francisco 76
Next Page